Insider Trading activities of Edge Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Edge Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Edge Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Edge Therapeutics, Inc. since 2005. The reporting company's ticker symbol is EDGE. The reporting company's CIK number is 1472091.
The total value of stock buying since 2005 is $15,107,640.
The total value of stock sales since 2005 is $847,989.
The total value of stock option exercises since 2005 is $127,950.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Edge Therapeutics, Inc. (EDGE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 7,500 $73,925 0 $0
2017-11 0 $0 10,861 $115,410 0 $0
2017-10 0 $0 7,500 $82,200 0 $0
2017-09 0 $0 7,500 $76,549 0 $0
2017-08 0 $0 11,000 $115,390 0 $0
2017-07 0 $0 7,500 $76,400 0 $0
2017-04 0 $0 100 $1,110 0 $0
2017-03 3,000 $27,720 0 $0 0 $0
2017-02 0 $0 7,500 $71,580 0 $0
2017-01 0 $0 0 $0 25,000 $51,000
2016-12 0 $0 7,500 $87,000 0 $0
2016-10 0 $0 7,500 $76,845 0 $0
2016-08 10,000 $94,792 7,500 $71,580 0 $0
2016-06 0 $0 0 $0 15,000 $76,950
2016-03 544,343 $3,974,678 0 $0 0 $0
2015-10 1,000,950 $11,010,450 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Edge Therapeutics, Inc. insiders (EDGE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-05 Leuthner Brian A (President and CEO) Sale 2,500 9.68 24,200
2017-12-04 Leuthner Brian A (President and CEO) Sale 2,500 9.97 24,925
2017-12-01 Leuthner Brian A (President and CEO) Sale 2,500 9.92 24,800
2017-11-22 Marchio Albert N Ii (Chief Accounting & Adm Officer) Sale 3,361 10.00 33,610
2017-11-03 Leuthner Brian A (President and CEO) Sale 2,500 10.86 27,150
2017-11-02 Leuthner Brian A (President and CEO) Sale 2,500 10.94 27,350
2017-11-01 Leuthner Brian A (President and CEO) Sale 2,500 10.92 27,300
2017-10-04 Leuthner Brian A (President and CEO) Sale 2,500 11.14 27,850
2017-10-03 Leuthner Brian A (President and CEO) Sale 2,500 10.93 27,325
2017-10-02 Leuthner Brian A (President and CEO) Sale 2,500 10.81 27,025
2017-09-06 Leuthner Brian A (President and CEO) Sale 2,500 10.31 25,775
2017-09-05 Leuthner Brian A (President and CEO) Sale 2,500 9.94 24,850
2017-09-01 Leuthner Brian A (President and CEO) Sale 2,500 10.37 25,924
2017-08-29 Marchio Albert N Ii (Chief Accounting & Adm Officer) Sale 2,500 10.42 26,050
2017-08-23 Marchio Albert N Ii (Chief Accounting & Adm Officer) Sale 1,000 10.39 10,390
2017-08-03 Leuthner Brian A (President and CEO) Sale 2,500 10.40 26,000
2017-08-02 Leuthner Brian A (President and CEO) Sale 2,500 10.53 26,325
2017-08-01 Leuthner Brian A (President and CEO) Sale 2,500 10.65 26,625
2017-07-06 Leuthner Brian A (President and CEO) Sale 2,500 10.08 25,200
2017-07-05 Leuthner Brian A (President and CEO) Sale 2,500 10.21 25,525
2017-07-03 Leuthner Brian A (President and CEO) Sale 2,500 10.27 25,675
2017-04-26 Leuthner Brian A (President and CEO) Sale 100 11.10 1,110
2017-03-06 Loughlin James J (Director) Buy 3,000 9.24 27,720
2017-02-07 Leuthner Brian A (President and CEO) Sale 1,500 9.52 14,280
2017-02-06 Leuthner Brian A (President and CEO) Sale 1,500 9.52 14,280
2017-02-03 Leuthner Brian A (President and CEO) Sale 1,500 9.69 14,535
2017-02-02 Leuthner Brian A (President and CEO) Sale 1,500 9.61 14,415
2017-02-01 Leuthner Brian A (President and CEO) Sale 1,500 9.38 14,070
2017-01-23 Macdonald R. Loch (Chief Scientific Officer) Option Ex 25,000 2.04 51,000
2016-12-01 Leuthner Brian A (President and CEO) Sale 7,500 11.60 87,000
2016-10-03 Leuthner Brian A (President and CEO) Sale 7,500 10.25 76,845
2016-08-08 Middlekauff W Bradford (Senior VP, GC and Secretary) Buy 143 9.43 1,348
2016-08-05 Middlekauff W Bradford (Senior VP, GC and Secretary) Buy 9,857 9.48 93,444
2016-08-01 Leuthner Brian A (President and CEO) Sale 7,500 9.54 71,580
2016-06-16 Vaish Renu (V.P., Global Reg. Affairs) Option Ex 10,000 5.13 51,300
2016-03-11 Loughlin James J (Director) Buy 3,000 7.62 22,875
2016-03-11 Healy James Buy 541,343 7.30 3,951,803
2015-10-06 Vaish Renu (V.P., Global Reg. Affairs) Buy 350 11.00 3,850
2015-10-06 Faleck Herbert J (Chief Medical Officer) Buy 500 11.00 5,500
2015-10-06 Einhorn Andrew J. (Chief Financial Officer) Buy 45,000 11.00 495,000
2015-10-06 Spiegel Robert J. Buy 3,000 11.00 33,000
2015-10-06 Hove Anders D Buy 450,000 11.00 4,950,000
2015-10-06 Loughlin James J Buy 7,000 11.00 77,000
2015-10-06 Barer Sol J Buy 45,000 11.00 495,000
2015-10-06 Healy James Buy 450,000 11.00 4,950,000
2015-10-06 Marchio Albert N Ii (Chief Acct. & Op., Asst. Sec.) Buy 100 11.00 1,100

Insider trading activities including stock purchases, stock sales, and option exercises of EDGE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Edge Therapeutics, Inc. (symbol EDGE, CIK number 1472091) see the Securities and Exchange Commission (SEC) website.